StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
OTLKBullishAnalyst Target Updateanalyst
Medium materiality6/10

Outlook Therapeutics price target raised to $1.60 from 50c at H.C. Wainwright

Jul 27, 2026, 3:01 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Upside potential driven by the target upgrade; price move since signal supports positive sentiment.

AI summary

What happened, with direct paths to the underlying reporting

Analyst target raised to $1.60; posted price $1.08; priceChangeSinceSignal +2.32; firm: H.C. Wainwright; analyst: Douglas Tsao.

  • Target raised to $1.60; posted price $1.08; priceChange +2.32; Firm: H.C. Wainwright; Analyst: Douglas Tsao

Key facts

  1. 01

    Target: $1.6

  2. 02

    Posted price: $1.08

  3. 03

    Analyst firm: H.C. Wainwright

  4. 04

    Analyst: Douglas Tsao

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event